These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Small size nanoparticles-Co3O4 based lateral flow immunoassay biosensor for highly sensitive and rapid detection of furazolidone.
    Author: Su L, Wang L, Yao X, Yin X, Zhang H, Zhao M, Liu S, Wang Z, Wang J, Zhang D.
    Journal: Talanta; 2020 May 01; 211():120729. PubMed ID: 32070592.
    Abstract:
    Lateral flow immunoassay (LFIA) biosensor is a paper-based tool and widely utilized in various fields. Here, we developed a novel LFIA biosensor by introducing Co3O4 nanoparticles (NPs) as signal labels for highly sensitive detection of 3-amino-2-oxazolidinone (AOZ), a metabolite of furazolidone. The characteristic brown color of Co3O4 NPs enabled AOZ to be visually detected by the LFIA. Significantly, the size of Co3O4 NPs is relatively small compared with most of other signal labels, which could remarkably reduce steric hindrance, increase immunoreaction probability and shorten the analysis time. Under optimal conditions, the novel Co3O4 NPs-LFIA could possess high sensitivity for the detection of AOZ with a detection limit of 0.4 ng mL-1 by naked eyes, which was at least 3-fold improved than that of the conventional gold nanoparticles (GNPs) based LFIA. Moreover, the detection could be achieved within 6 min and without cross-reactions with other analogue small molecules. Taking merits of convenience, rapid and sensitivity, the proposed Co3O4 NPs-LFIA may be readily adapted for the detection of other small molecules.
    [Abstract] [Full Text] [Related] [New Search]